Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Want a daily digest of the top Nashville news?
Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.
Want a daily digest of the top Columbus news?
Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.
Want a daily digest of the top Dallas news?
Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
Oxycodone pain pills. Photo: John Moore/Getty Images
Rochester Drug Cooperative became the first drug distributor to receive criminal charges relating to its role in the opioid epidemic, the Department of Justice announced yesterday.
The bottom line: The company "prioritized attracting business, catering to existing customers, and making money above all else," the complaint reads.
Details: Rochester agreed to a $20 million settlement with the Southern District of New York and the Drug Enforcement Administration, and admitted to an outlined statement of facts regarding its conduct.
- 2 Rochester executives were also charged yesterday and face possible jail time. One has pleaded guilty.
By the numbers: This penalty pales in comparison with how much Rochester made distributing opioids to pharmacies, including ones that exhibited red flags suggesting they were dispensing opioids illicitly at the height of the opioid epidemic.
- Rochester's oxycodone distribution grew from 4.7 million tablets in 2012 to 42.2 million in 2016.
- Its fentanyl distribution grew from about 63,500 dosages in 2012 to about 2.4 million in 2015, and 1.3 million in 2016.
- Rochester made about $1.2 billion from sales of controlled substances between 2012 and 2016.
- It then turned around and paid dividends to some of its largest pharmacy purchasers, which were also shareholders. In 2015, it paid a $10.6 million dividend to its largest customer — a pharmacy that was one of the nation's largest dispensers of Subsys, a highly-addictive fentanyl spray.
Go deeper ... Exclusive: Lawsuit says Johnson & Johnson was opioid "kingpin"